To view the PDF file, sign up for a MySharenet subscription.

CILO CYBIN HOLDINGS LIMITED - Update of IPO dates - extension of closing date to Friday 18 November

Release Date: 08/11/2022 08:45
Code(s): CCC     PDF:  
Wrap Text
Update of IPO dates - extension of closing date to Friday 18 November

CILO CYBIN HOLDINGS LIMITED
(Incorporated in South Africa)
(Registration number 2022/320351/06)
Ordinary Shares Share code: CCC
ISIN: ZAE000310397
(“the Company”)


UPDATE OF IPO DATES – EXTENSION OF CLOSING DATE TO FRIDAY 18 NOVEMBER


Further to the Exchange News Service of the JSE Limited announcement on 12 September where Cilo Cybin
Holdings Limited informed the market of its intention to raise a Minimum Amount of R500 million by means of an
IPO and list on the JSE main board, the Company would like to remind interested investors of the dates as set out
in the Prospectus.

Cilo Cybin Holdings Limited was incorporated by the Founder, Gabriel Theron, for the purposes of being listed on
the Main Board of the JSE with effect from the commencement of trade on Monday, 14 November 2022, as a special
purpose acquisition company to pursue acquisitions of, and investments in, commercial enterprises operating in
the Biotech, Biohacking or Pharmaceutical sector that will enable it to develop and expand methodologies
by utilising Artificial Intelligence (AI) and expertise of medical specialists to deliver holistic and individualised
solutions to customers to better their health, performance and increase their longevity. The Prospectus and other
supporting documentation are available on the website.

At the close of business on Friday, 4 November there were already 1105 members of the public that had subscribed
for shares.

Several institutional investors expressed an interest in participating in the Offer but are still busy evaluating the
opportunity and requested an extension to the published timelines. The Board evaluated the request and believed
that it is in the best interest of the Company to extend the offer period.

On page 25 of the Prospectus in the section under heading “SALIENT DATES AND TIMES1” in note 1 to the table
it is indicated that:
“Notes:
(1) All references to dates and time are to local dates and times in South Africa. These dates and times are
subject to amendment. Any such amendment will be released on SENS and published in the press.”

The supplement to the Prospects with an extension to the dates, as set out in the table below, was registered with
CIPC on 4 November 2022.

DATES AND TIMES FOR IPO

                                                                                                2022
 Opening date of the IPO (09h00)                                                Monday, 12 September
 Closing date of the IPO (12h00)                                                 Friday, 18 November
 Finalisation Results of the IPO released on SENS                               Tuesday, 22 November
 Notification of allotments to successful investors by                          Tuesday, 22 November
 Finalisation Results of the IPO published in the press on                    Wednesday, 23 November
 Proposed date of Listing (09h00)                                                Monday, 28 November

To register an interest in the IPO and to receive IPO related documentation send an email to ipo@cilocybin.com or
visit www.cilocybin.com

By order of the Board
Midrand
8 November 2022

Sponsor
DEA-RU Proprietary Limited

Date: 08-11-2022 08:45:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.